Inventor
HUSE WILLIAM D
US54 patents
⚠️ This page may combine multiple inventors who share the name “HUSE WILLIAM D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IXSYS INC
19 patentsUS5955358ASep 21, 1999
Optimization of binding proteins
IXSYS INC201 citations99
US5770434AJun 23, 1998
Soluble peptides having constrained, secondary conformation in solution and method of making same
IXSYS INC206 citations99
US5698426ADec 16, 1997
Surface expression libraries of heteromeric receptors
IXSYS INC1,317 citations99
US5523388AJun 4, 1996
Methods of synthesizing oligonucleotides with random codons
IXSYS INC105 citations99
US5264563ANov 23, 1993
Process for synthesizing oligonucleotides with random codons
IXSYS INC325 citations99
US5871974AFeb 16, 1999
Surface expression libraries of heteromeric receptors
IXSYS INC109 citations98
US6531580B1Mar 11, 2003
Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
IXSYS INC67 citations96
US5862514AJan 19, 1999
Method and means for synthesis-based simulation of chemicals having biological functions
IXSYS INC70 citations96
US5808022ASep 15, 1998
Oligonucleotides having random riplets
IXSYS INC80 citations96
US5780426AJul 14, 1998
Fivemer cyclic peptide inhibitors of diseases involving αv β3
IXSYS INC137 citations96
US5767071AJun 16, 1998
Sevenmer cyclic peptide inhibitors of diseases involving αv β3
IXSYS INC101 citations96
US6849425B1Feb 1, 2005
Methods of optimizing antibody variable region binding affinity
IXSYS INC37 citations93
US6596850B1Jul 22, 2003
Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
IXSYS INC27 citations93
US6348194B1Feb 19, 2002
Tumor specific internalizing antigens and methods for targeting therapeutic agents
IXSYS INC31 citations93
US6331431B1Dec 18, 2001
Vacuum device and method for isolating periplasmic fraction from cells
IXSYS INC19 citations91
US6590079B2Jul 8, 2003
Anti-αvβ3 recombinant human antibodies, nucleic acids encoding same
IXSYS INC28 citations90
US6420126B1Jul 16, 2002
Tumor specific internalizing antigens and methods for targeting therapeutic agents
IXSYS INC5 citations74
US6258530B1Jul 10, 2001
Surface expression libraries of randomized peptides
IXSYS INC14 citations74
US6027933AFeb 22, 2000
Surface expression libraries of heteromeric receptors
IXSYS INC13 citations74
APPLIED MOLECULAR EVOLUTION
7 patentsUS7371382B2May 13, 2008
Methods of inhibiting αvβ3-mediated binding with αvβ3-specific antibodies
APPLIED MOLECULAR EVOLUTION11 citations84
US7175996B1Feb 13, 2007
Methods of optimizing antibody variable region binding affinity
APPLIED MOLECULAR EVOLUTION14 citations84
US6893845B1May 17, 2005
Surface expression libraries of heteromeric receptors
APPLIED MOLECULAR EVOLUTION15 citations84
US6787638B1Sep 7, 2004
Tumor specific human monoclonal antibodies and methods of use
APPLIED MOLECULAR EVOLUTION17 citations84
US7422744B2Sep 9, 2008
Methods of treating cancer with alphavbeta3-specific antibodies
APPLIED MOLECULAR EVOLUTION12 citations82
US7101978B2Sep 5, 2006
TNF-α binding molecules
APPLIED MOLECULAR EVOLUTION9 citations71
US7667007B2Feb 23, 2010
αvβ3-specific antibodies
APPLIED MOLECULAR EVOLUTION0 citations52
MEDIMMUNE LLC
5 patentsUS7700735B2Apr 20, 2010
High potency recombinant antibodies and method for producing them
MEDIMMUNE LLC57 citations98
US7553489B2Jun 30, 2009
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE LLC44 citations96
US7740851B2Jun 22, 2010
Ultra high affinity neutralizing antibodies
MEDIMMUNE LLC35 citations93
US7847082B2Dec 7, 2010
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE LLC26 citations92
US7635568B2Dec 22, 2009
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE LLC39 citations92
MEDIMMUNE INC
5 patentsUS7229619B1Jun 12, 2007
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE INC114 citations98
US6855493B2Feb 15, 2005
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE INC72 citations98
US6656467B2Dec 2, 2003
Ultra high affinity neutralizing antibodies
MEDIMMUNE INC96 citations98
US7323172B2Jan 29, 2008
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE INC48 citations96
US7179900B2Feb 20, 2007
Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
MEDIMMUNE INC45 citations96
STRATAGENE INC
5 patentsUS5354656AOct 11, 1994
Method of DNA sequencing
STRATAGENE INC38 citations93
US5413708AMay 9, 1995
Push column chromatography apparatus
STRATAGENE INC22 citations91
US5336412AAug 9, 1994
Push column chromatography method
STRATAGENE INC32 citations91
US5378360AJan 3, 1995
Push column and chromatography apparatus
STRATAGENE INC15 citations80
US7858359B2Dec 28, 2010
Method for tapping the immunological repertoire
STRATAGENE INC0 citations52
CELL MATRIX INC
4 patentsUS7365167B2Apr 29, 2008
Humanized collagen antibodies and related methods
CELL MATRIX INC21 citations91
US7566770B2Jul 28, 2009
Humanized collagen antibodies and related methods
CELL MATRIX INC12 citations83
US7390885B2Jun 24, 2008
Humanized collagen antibodies and related methods
CELL MATRIX INC11 citations83
US7763247B2Jul 27, 2010
Humanized collagen antibodies and related methods
CELL MATRIX INC6 citations72
SCRIPPS RESEARCH INST
2 patents(unassigned)
1 patentYOUNG JAMES F
1 patentSTRATEGENE
1 patentShowing the top 50 of 54 patents by PatentIndex Score.